Trevor Jensen is the new Director for the Procedures Service.
Lena Loo has been promoted to Administrative Officer 3 as Rosemary Yau’s former position.
Akshay Ravi presented a poster at the 2022 AMIA Clinical Informatics Conference about a new approach to clinical informatics education to improve diversity and inclusion in informatics.
The Hospital Medicine: Evidence to Practice Course, chaired by Brad Sharpe, covered the clinical issues most relevant to hospitalists and other clinicians who care for inpatients and highlighted recent advances and current controversies. This course was held at The Royal Hawaiian Hotel, June 22-24, 2022.
Equity & Belonging in Hospital Medicine
"No one is going to give you the education you need to overthrow them. Nobody’s going to teach you your true history, teach you your true heroes, if they know that That knowledge will help set you free."
For feedback, comments, or to share pearls in the next DHM newsletter, please email Yalda.Shahram@ucsf.edu
Publications
Stephanie Rogers, James Harrison, and colleagues have published a landscape assessment of Acute Care for Elders (ACE) Units. This study, published in the Journal of the American Geriatrics Society, identifies existing ACE units in the United States and describes variations in implementation.
Akshay Raviwas a coauthor on a new study accepted by the Journal of Neurosurgery which evaluated a machine learning model to predict risk of recurrence for WHO Grade I Meningiomas after complete resection.
Ashraf Abugroun was coauthor on a study in Cardiovascular Revascularization Medicine that sought to determine whether newly diagnosed atrial fibrillation predicted cardiovascular events and death after myocardial infarction in a large nationwide cohort of patients. The study showed that AF is a significant predictor of mortality, acute myocardial infarction, and stroke. Neither age, race nor sex modified the effects of AF on these outcomes.
Ashraf Abugroun was coauthor a study in Diabetes Epidemiology and Management that sought to investigate the impact of hydroxychloroquine on the risk of diabetes mellitus in patients with systemic lupus erythematosus. The study provides further evidence for the antidiabetic effect of hydroxychloroquine in a lupus cohort.
Margaret Fang, Priya Prasad, and colleagues were coauthors on a study published in Thrombosis Research. They surveyed 2230 people taking anticoagulants for venous thromboembolism and found that although treatment satisfaction may be higher with DOACs, there is no difference in health-related quality of life between DOAC and warfarin users.
